Operose Advisors »

Immunitybio shares owned by Operose Advisors

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Operose Advisors from 13F filings

Historical chart of Operose Advisors investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Operose Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Operose Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $543k 62k 8.76

More positions owned by Operose Advisors

Vanguard Total Stock Market ETF Etf (VTI)
Vanguard High Dividend Yield ETF Etf (VYM)
Vanguard FTSE Developed Markets ETF Etf (VEA)
Schwab International Equity ETF Etf (SCHF)
Vanguard S&P 500 ETF Etf (VOO)
iShares Core S&P Small-Cap ETF Etf (IJR)
Invesco S&P 500 Equal Weight ETF Etf (RSP)
Spdr S&p 500 Etf Etf (SPY)
Vanguard Mid-Cap ETF Etf (VO)
Vanguard Mid-Cap Growth ETF Etf (VOT)
Broadcom Common (AVGO)
NVIDIA Corp Common (NVDA)
Apple Common (AAPL)
iShares Russell 2000 ETF Etf (IWM)
Advanced Micro Devices Common (AMD)

View all positions for Operose Advisors

Top funds holding Immunitybio

BlackRock
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
D. E. Shaw & Co
Two Sigma Investments
Geode Capital Management
Susquehanna International
Citadel Advisors
Millennium Management
LMR Partners
Morgan Stanley
Northern Trust
Goldman Sachs Group
UBS Group

View all funds holding Immunitybio